Induction of Clinical Response Using Rifaximin in Crohn's Disease

Clinical trial NCT00603616 · COMPLETED

Trial details

NCT number: NCT00603616
Sponsor: Scott Lee
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2008-11-01
Primary completion: 2020-11-03
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.